Alnylam Canada ULC is pleased to announce that GIVLAARI® (givosiran injection) is now funded across Canada through both public and private insurance plans for patients living with acute hepatic ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Ionis Pharmaceuticals, Inc. for the ...

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and ...

Alcohol-related liver disease (ARLD) is a serious health problem that can develop when the liver is repeatedly exposed to excessive alcohol. The liver, a vital organ responsible for detoxifying the ...

Arrowhead Pharmaceuticals, Inc. today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-INHBE, the company's investigational RNA interference (RNAi) therapeutic ...

Discover a study where findings suggest that dihydroxyacetone phosphate, along with alanine transaminase, could serve as a ...

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with ...

While radishes have always been known for adding crunch and pop to food, new research has said that this vegetable actively ...

In everyday life, when things turn out the opposite of what you expect, it's usually cause for frustration. In science, it's ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis ...